Our Latest Thinking on the Health Care Industry

Explore BCG’s latest thought leadership on health care to plan your company’s next move.

Featured Insights

Biopharma

Gene Editing Gets Ready for the Spotlight | Rectangle

Gene Editing Gets Ready for the Spotlight

Pharma has invested billions in cell and gene therapies. Gene editing is making a case for more of this funding, but companies need to understand what they’re investing in and why.

Health Care Payers, Providers, Systems, and Services

How Health Insurers Can Keep Talent and Cut Costs | rectangle

How Health Insurers Can Keep Talent and Cut Costs

A confluence of factors means the time-tested approaches to cost control won’t work. Insurers need to rethink how they achieve more with less while maintaining a strong customer focus and employee value proposition.

Medical Devices and Technology

Why Ottobock Leads with “Social” in ESG: An Interview with CEO Philipp Schulte-Noelle

A global leader in prostheses, Ottobock set out to also become the ESG leader in its field. The key: measuring the socioeconomic benefit of its products.

Global Health

Sideways image of a people-moving conveyor belt with social distancing marks

Reimagining Global Health After the Coronavirus

What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?

What It Takes to Crush a Pandemic

BCG Managing Director & Partner Johanna Benesty looks at barriers to "equitable access"—making sure COVID-19 therapeutics are available to all—while sharing a creative approach to vaccine research and development.


Expert Videos

protected by reCaptcha

Shape the Future of Health Care: The latest insights on the future of the industry.

Health Care Industry

SUBSCRIBE